SCHEMBL10258491

SCHEMBL10258491

CC(C)C(=O)C(CNCCO)c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 5/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 2/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 1/20 0.40
BRD4 O60885 1/20 0.39
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CACNA1G O43497 1/20 0.37
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680992 0.87 AKT1 (0.43) FFAR2SMN1; SMN2L3MBTL1POLBRAB9A
SCHEMBL8227309 0.85 FFAR2 (0.44) FFAR2SMN1; SMN2L3MBTL1POLBBRD4
SCHEMBL14310526 0.85 BRD4 (0.49) FFAR2SMN1; SMN2L3MBTL1KDM4EPOLB
SCHEMBL679637 0.85 AKT1 (0.45) FFAR2SMN1; SMN2L3MBTL1KDM4EPOLB
SCHEMBL681207 0.82 FFAR2 (0.42) FFAR2SMN1; SMN2L3MBTL1POLBALDH1A1
SCHEMBL12104141 0.82 KDM4E (0.40) FFAR2SMN1; SMN2L3MBTL1KDM4EPOLB
SCHEMBL680742 0.81 FFAR2 (0.41) FFAR2SMN1; SMN2L3MBTL1POLBRAB9A
SCHEMBL680697 0.81 FFAR2 (0.41) FFAR2SMN1; SMN2L3MBTL1POLBRAB9A
SCHEMBL681425 0.81 FFAR2 (0.44) FFAR2L3MBTL1POLBALDH1A1RAB9A
SCHEMBL680933 0.81 KDM4E (0.40) FFAR2L3MBTL1KDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402325-A2 Hydroxylated and methoxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Array Biopharma, Inc. (US) 2012-01-04 EP disclosed
EP-2399909-A1 Hydroxylated and methoxylated cyclopenta[d]pyrimidines as akt protein kinase inhibitors Array Biopharma, Inc. (US) 2011-12-28 EP disclosed